A 5.9 billion sales were recorded for Eylea in the year 2023
Additional risk factors include: Chronic kidney disease : Reduced renal clearance may impair B12 excretion Liver disease : Hepatic dysfunction can disrupt B12 metabolism and storage Myeloproliferative disorders : Certain blood cancers increase B12-binding proteins Concurrent medication use : Some drugs may interact with B12 metabolism, including metformin, proton pump inhibitors, and H2 antagonists Patients with these conditions should have B12 supplementation carefully monitored by their healthcare team
Another study done in 2017 discussed the overlapping symptoms of ADHD and a type of dementia called mild cognitive impairment
Escott et al., 2022), together with a positive sensory impact
Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, et al
Tenderness or mild pain